Document Detail


Prescribing without evidence - pregnancy.
MedLine Citation:
PMID:  22607226     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prescribing of medicines during pregnancy is common, and for some groups of women is essential for maintaining maternal and therefore fetal health. Pregnant women and prescribers are rightly concerned, however, about the potential adverse fetal effects of medicines. These may include fetal death or stillbirth, congenital malformations, developmental impairment, neonatal effects or late carcinogenesis. It is therefore essential that the risks and benefits for mother and fetus are considered carefully before prescribing in pregnancy. This is often challenging because of the paucity of information available. To complicate the issue further, drug pharmacokinetics are commonly altered in pregnancy, potentially affecting optimal dosing as well as interpretation of plasma concentration measurements, with specific information on individual drugs seldom available. Most drugs cross the placenta, especially lipophilic drugs and those with low plasma protein binding. Active membrane transporters also have an important role in enhancing or preventing drug transfer, although this is not yet clearly understood. Animal studies have limited applicability to humans because of species-specific effects, and clinical trials in pregnancy are only undertaken in special circumstances. Prescribers therefore need to rely on observational studies of fetal outcomes following drug exposure in human pregnancy. These often involve limited numbers, and data are also subject to confounding and bias, making interpretation difficult. It therefore remains essential that appropriate mechanisms for systematic data collection, including congenital malformation registries, teratology information services, pregnancy registers and linked population registries, are maintained and enhanced to increase the amount and quality of information available.
Authors:
Simon H L Thomas; Laura M Yates
Related Documents :
22174426 - Pregnancy outcome following exposure to topical retinoids: a multicenter prospective st...
21748316 - Severe h1n1-infection during pregnancy.
21769896 - Quantification of free fetal dna in multiple pregnancies and relationship with chorioni...
22254096 - Iodine deficiency in pregnancy: the effect on neurodevelopment in the child.
16011146 - Bovine il-18 elisa: detection of il-18 in sera of pregnant cow and newborn calf, and in...
24697006 - Wilson's disease in pregnancy.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  74     ISSN:  1365-2125     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-06     Completed Date:  2013-02-04     Revised Date:  2013-10-11    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  691-7     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.
Affiliation:
UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK. simon.thomas@ncl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adverse Drug Reaction Reporting Systems
Databases, Pharmaceutical
Drug Prescriptions / standards*
Drug Toxicity / prevention & control*
Female
Fetus / drug effects*
Humans
Pregnancy
Pregnant Women*
Registries
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low Incidence of Bleeding-Related Morbidity With Left Ventricular Assist Device Implantation in the ...
Next Document:  Integrated mosquito larval source management reduces larval numbers in two highland villages in west...